| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31e05e9223230e886383df19777ee778
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54844c99385d5e8915aa8069146ce5ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ccae79630656204079bf2675f6883d5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db35240151bbdfcdea85d1aa3e4d9ec4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate |
2011-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bc3233302ce81d9b478716be25cd30d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aed610943d773b758f09cc1b267a0092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6bc4c295c48e71dd4e246cb2cec68d6 |
| publicationDate |
2013-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013072499-A1 |
| titleOfInvention |
PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS |
| abstract |
The present invention relates to novel piperazine compounds; to pharmaceutical compositions containing the compounds; and to the use of the compounds in therapy to treat diseases for which blocking the Ca v 2.2 calcium channels is beneficial and to treat diseases for which blocking the Ca v 2.2 and Ca v 3.2 calcium channels is beneficial, e.g. to treat pain. |
| priorityDate |
2010-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |